FDA issues Darvon and Darvocet recall due to risk of heart problems

FDA issues Darvon and Darvocet recall due to risk of heart problems

San Francisco : CA : USA | Nov 20, 2010 at 12:49 AM PST
Views: Pending
Propoxyphene has been on the US market since it was first approved by the FDA in 1957

It has been announced by FDA that Darvon and Darvocet recall has been issued after the new clinical research indicates that the painkiller drugs can cause heart-related side effects. Along with Darvocet recall, FDA has also ordered generic drug makers to drop marketing of low-cost drugs that contain the active ingredient in Darvon called propoxyphene.

In 1957, FDA approved Propoxyphene, an opioid used to treat mild to moderate pain, but later the drug was questioned over safety concerns. Since 1978, two Darvocet recalls have been requested by the FDA, but they concluded that the benefits overweigh the health risks.

It has been discovered through electrocardiography that abnormalities occurred in healthy people who take normal doses of Darvon and Darvocet. Since 2005, almost 120 million patients in the U.S. have been prescribed with Darvocet, which combines propoxyphene with common painkiller acetaminophen.

After the official Darvon and Darvocet recall, doctors are being asked to stop prescribing propoxyphene to their patients.

1 of 2
Darvocet Recall
FDA announced Darvon and Darvocet recall.
faliciasmith is based in Philadelphia, Pennsylvania, United States of America, and is an Anchor on Allvoices.
Report Credibility
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear

News Stories

  • Painkiller taken off the market

      The Journal Gazette
    The Food and Drug Administration said Friday that Xanodyne Pharmaceuticals had agreed to halt all U.S. marketing of Darvon and the related brand Darvocet, which have been subject to safety concerns for decades. The Kentucky company confirmed the move...
  • Wrong Answer Dr. Jenkins!

      Salem News
    I was invited - as credentialed media - to participate in a U.S. Food and Drug Administration (FDA) media briefing on November 19, 2010 to discuss a "drug safety issue". A controversial painkiller Darvocet or Darvon as well as other brand/generic...


  • Darvocet-Darvon Painkiller Drugs Withdrawn at FDA Request - TPROne

    The FDA has determined that recent clinical research shows that using propoxyphene in Darvon and Darvocet increases the chances of developing heart rhythm problems which can be possibly deadly. The FDA is requesting the withdrawal and ...
  • Darvocet Recall

    The U.S. Food and Drug Administration have announced that both Darvon and Darvocet painkiller drugs, which use the active ingredient propoxyphene, have been pulled from the U.S. market in agreement with Xanodyne Pharmaceuticals Inc. ...
  • UPDATE: FDA recalls painkiller drugs Darvon and Darvocet » Health ...

    The highly debated prescription painkillers, Darvon and Darvocet (propoxyphene) were pulled off the market Friday at the request of the Food and Drug.
  • Darvocet Recall

    Potentially Fatal Heart Abnormalities Final Straw in Darvocet Recall Xanodyne Pharmaceuticals, Inc. is cooperating with the FDA in recalling Darvocet and Darvon , their versions of the pain killer propoxyphene. ...
  • Darvocet recall

    http://www.schmidtandclark.com/darvocet. Darvon Darvocet FDA Recall February 2009 – An advisory committee to the U.S. Food and Drug Administration (FDA) has recommended that the FDA recall Darvon, a popular painkiller also sold in. ...
  • Auto Blog: Darvocet Recall

    Darvocet Recall A panel of outside advisors to the FDA have recommended that the agency withdraw approval for the painkiller Darvon, which is also sold as Darvocet with the Update: On 1/30/09 an advisory committee to the U.S. Food ...



More From Allvoices

Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.